Receptor Activator of NF-UB Recruits Multiple TRAF Family Adaptors and Activates C-Jun N-Terminal Kinase

Total Page:16

File Type:pdf, Size:1020Kb

Receptor Activator of NF-UB Recruits Multiple TRAF Family Adaptors and Activates C-Jun N-Terminal Kinase FEBS 21470 FEBS Letters 443 (1999) 297^302 Receptor activator of NF-UB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase Hong-Hee Kima, Da Eun Leea, Jin Na Shina, Yong Soo Leea, Yoo Mi Jeona, Chae-Heon Chunga, Jian Nib, Byoung Se Kwonc, Zang Hee Leea;* aDepartment of Microbiology and Immunology, Chosun University Dental School, 375 Seosuk-Dong, Dong-Ku, Kwangju 501-759, South Korea bHuman Genome Sciences, Inc., Rockville, MD 20850, USA cDepartment of Life Sciences, Ulsan University, Ulsan, South Korea Received 7 December 1998 trabecular bone and lower in spleen and bone marrow [3], Abstract Receptor activator of NF-UB (RANK) is a recently cloned member of the tumor necrosis factor receptor (TNFR) which suggests physiological functions of RANK in the regu- superfamily, and its function has been implicated in osteoclast lation of bone and immune systems. Consistent with this differentiation and dendritic cell survival. Many of the TNFR suggestion, treatment with RANKL/TRANCE was shown family receptors recruit various members of the TNF receptor- to enhance the function and survival of T cells and dendritic associated factor (TRAF) family for transduction of their signals cells [1,5]. In addition, RANKL/ODF has been demonstrated to NF-UB and c-Jun N-terminal kinase. In this study, the to cause the di¡erentiation of hematopoietic precursor cells involvement of TRAF family members and the activation of the into osteoclasts and to stimulate the bone resorbing activity JNK pathway in signal transduction by RANK were investi- of mature osteoclasts [4]. gated. TRAF1, 2, 3, 5, and 6 were found to bind RANK in vitro. The TNF receptor-associated factor (TRAF) family mole- Association of RANK with each of these TRAF proteins was also cules are cytoplasmic adaptor proteins known to mediate sig- detected in vivo. Expression of RANK in cultured cells also induced the activation of JNK, which was blocked by a naling events speci¢cally for members of the TNFR family, dominant-negative form of JNK. Furthermore, by employing which includes TNFR1, TNFR2, CD30, CD40, CD27, Fas, various C-terminal deletion mutants of RANK, the regions 4-1BB, Ox40, TR2, and LMP-1 [6,7]. To date six members of responsible for TRAF interaction and JNK activation were the TRAF family have been identi¢ed. The TRAF2 protein is identified. TRAF5 was determined to bind to the C-terminal 11 recruited to TNFR1 through a death domain-containing mol- amino acids and the other TRAF members to a region N- ecule TRADD, whereas all TRAF proteins except TRAF4, terminal to the TRAF5 binding site. The domain responsible for which is localized to the nucleus, have been shown to directly JNK activation was localized to the same region where TRAF1, bind to several TNFR family receptors [8^17]. TRAF family 2, 3, and 6 bound, which suggests that these TRAF molecules proteins have a similar structural array consisting of an N- might mediate the RANK-induced JNK activation. terminal zinc RING ¢nger, multiple zinc ¢ngers, and C-ter- z 1999 Federation of European Biochemical Societies. minal TRAF-N and TRAF-C domains. The TRAF1 molecule Key words: Receptor activator of neclear factor UB; is unique in that it lacks the RING ¢nger domain [9]. The N- Tumor necrosis factor receptor-associated factor; terminal zinc binding regions of TRAFs serve as e¡ector do- c-Jun N-terminal kinase; Signal transduction mains, whereas the TRAF domain appears to be involved in binding to the cytoplasmic tail of TNFR proteins [12,18,19]. Characterization of binding sites for TRAFs in TNFR family proteins has led to the identi¢cation of two types of sequence 1. Introduction motif: PXQXT/S [20,21] and EED/EEE [15,20,22]. The PXQXT/S motif seems to be capable of binding to TRAFs Receptor activator of NF-UB (RANK) is a recently cloned 1, 2, 3, and 5 and the EED/EEE motif binds TRAFs 1, 2, and member of the tumor necrosis factor receptor (TNFR) family 3. Characteristic cellular responses to the stimulation of [1]. The RANK protein consists of 616 amino acids contain- TNFR family receptors include the activation of the NF-UB ing the cysteine residues conserved in the extracellular domain transcription factor and c-Jun N-terminal kinase (JNK) of the of the TNFR family proteins. Its relatively long cytoplasmic mitogen-activated protein kinase family. The N-terminal zinc domain (383 amino acids) has little homology with other binding motifs of TRAF2, TRAF5, and TRAF6 have been TNFR family members. The ligand for RANK, RANKL shown to be responsible for the NF-UB activation induced by [1], was found to be identical to TRANCE (TNF-related ac- TNFR family proteins [13^15,18,23^25]. Overexpression of tivation-induced cytokine), ODF (osteoclast di¡erentiation TRAF2, 5, or 6 was reported to activate JNK [26], and factor), and OPGL (osteoprotegerin ligand) [2^4]. The expres- TRAF2 has been implicated in the TNFK-induced activation sion level of RANK mRNA is high in thymus, lung, and of JNK [27]. The role of TRAF2 in the TNFR-induced JNK activation was further supported by a study with transgenic mice expressing a dominant-negative TRAF2 [28]. *Corresponding author. Fax: (82) (62) 227-6589. E-mail: [email protected] The activation of NF-UB appears to be involved in RANK signaling as other TNFR family proteins. Ectopic overexpres- Abbreviations: RANK, receptor activator of NF-UB; TNFR, tumor sion of RANK in a cultured cell line and ligation of endog- necrosis factor receptor; TRAF, tumor necrosis factor receptor- enous RANK in T cells pretreated with phytohemagglutinin associated factor; JNK, c-Jun N-terminal kinase; NF-UB, nuclear factor UB; GST, glutathione S-transferase; ICD, intracellular domain; and interleukin (IL)-4 resulted in NF-UB activation [1]. In- SEK, SAPK (JNK)/ERK kinase volvement of JNK in RANK signaling pathways might also 0014-5793/99/$19.00 ß 1999 Federation of European Biochemical Societies. All rights reserved. PII: S0014-5793(98)01731-1 FEBS 21470 1-2-99 298 H.-H. Kim et al./FEBS Letters 443 (1999) 297^302 be suggested as RANKL/TRANCE stimulation was shown to bu¡er and twice in the kinase reaction bu¡er, and kinase reaction cause a modest increase in the JNK activity in T cells [2]. As performed as previously described [31] with the omission of [Q-32P]ATP. Samples were resolved by SDS-PAGE and Western TRAF2, 5, and 6 were implicated in the activation of NF-UB blotted with an antibody speci¢c for phosphorylated c-Jun (New Eng- and JNK for some TNFR family members, it may be antici- land Biolabs, Cat. #9161S). Alternatively, the activity of endogenous pated that some TRAF molecules mediate the RANK-in- JNK was measured by the solid-phase kinase assay [32] using 3 Wgof duced responses. In support of this, the amino acid sequence GST-c-Jun-77. analysis of the cytoplasmic domain of human RANK reveals several potential TRAF binding sites: four PXQXT/S-like 3. Results and discussion motifs (302PDQGG, 353PSQPT, 569PVQEE, and 607PVQEQ) and three acidic residue triplets (336EED, 346EDE, and 3.1. Interaction of RANK with TRAF family proteins in vitro 481EEE). To gain insight into the mechanism by which Some TNFR family receptors recruit TRAF2, 5, and 6 to RANK transmits its signal to the nucleus, the interaction activate NF-UB [23^25], while this activation appears to be between RANK and TRAFs and the e¡ect of RANK signal- antagonized by TRAF3 binding [17,23,25]. To determine ing on JNK activation were characterized in this study. whether RANK can also utilize TRAF family proteins in signal transduction, the potential interaction between 2. Materials and methods RANK and TRAFs was examined by in vitro binding experi- ments, employing the GST fusion protein of the cytoplasmic 2.1. Cell culture and transfection domain of human RANK. When the GST-RANK protein HeLa cells were cultured in DMEM containing 10% FCS and 293- was incubated with lysates from HeLa or 293-EBNA cells EBNA cells (Invitrogen) were maintained in DMEM containing 10% FCS and 250 Wg/ml G418. For transient transfection, 2U105 cells per expressing Flag-tagged TRAF molecules (Fig. 1A) and the well were plated onto 6-well plates. The next day, transfection was precipitates were subjected to Western blotting with anti- carried out with a mixture of 1^2 Wg DNA and 10 Wl SuperFect Flag, TRAF1, 2, 3, 5, and 6 were found to bind RANK reagent (Qiagen) following the manufacturer's instructions. 40^48 h (Fig. 1B). The binding of TRAF to GST-RANK was speci¢c after transfection, cells were harvested. For co-immunoprecipitation as the GST control and the GST fusion of protein X, which experiments, 1.5U106 cells plated in T-25 £asks were transfected with 4^7 Wg DNA and 20 Wl SuperFect. does not possess any homology to RANK, showed little bind- ing, even though comparable amounts of the GST proteins 2.2. Plasmid constructions were used (data not shown). Although the possibility of the The cDNA encoding the full-length human RANK was obtained involvement of a third cellular protein mediating the interac- from Human Genome Sciences (Rockville, MD). The T7-tagged mammalian expression vector of hRANK, pSRa-RANK-T7, was con- tions between RANK and TRAFs cannot be excluded, given structed by PCR. The sequence of PCR product was veri¢ed by au- tomated DNA sequencing (Perkin Elmer, ABI 310). RANK C-termi- nal deletion mutants, pSRa-RANK-605 and -432, were generated using XhoI (amino acid 605 position) and MscI (amino acid 432 and 513 positions) sites, respectively.
Recommended publications
  • Mechanism of Action Through an IFN Type I-Independent Responses To
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 is online at: average * The Journal of Immunology , 12 of which you can access for free at: 2012; 188:3088-3098; Prepublished online 20 from submission to initial decision 4 weeks from acceptance to publication February 2012; doi: 10.4049/jimmunol.1101764 http://www.jimmunol.org/content/188/7/3088 MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action Elena Caproni, Elaine Tritto, Mario Cortese, Alessandro Muzzi, Flaviana Mosca, Elisabetta Monaci, Barbara Baudner, Anja Seubert and Ennio De Gregorio J Immunol cites 33 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription http://www.jimmunol.org/content/suppl/2012/02/21/jimmunol.110176 4.DC1 This article http://www.jimmunol.org/content/188/7/3088.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767
    [Show full text]
  • Expression of the Tumor Necrosis Factor Receptor-Associated Factors
    Expression of the Tumor Necrosis Factor Receptor- Associated Factors (TRAFs) 1 and 2 is a Characteristic Feature of Hodgkin and Reed-Sternberg Cells Keith F. Izban, M.D., Melek Ergin, M.D, Robert L. Martinez, B.A., HT(ASCP), Serhan Alkan, M.D. Department of Pathology, Loyola University Medical Center, Maywood, Illinois the HD cell lines. Although KMH2 showed weak Tumor necrosis factor receptor–associated factors expression, the remaining HD cell lines also lacked (TRAFs) are a recently established group of proteins TRAF5 protein. These data demonstrate that consti- involved in the intracellular signal transduction of tutive expression of TRAF1 and TRAF2 is a charac- several members of the tumor necrosis factor recep- teristic feature of HRS cells from both patient and tor (TNFR) superfamily. Recently, specific members cell line specimens. Furthermore, with the excep- of the TRAF family have been implicated in promot- tion of TRAF1 expression, HRS cells from the three ing cell survival as well as activation of the tran- HD cell lines showed similar TRAF protein expres- ␬ scription factor NF- B. We investigated the consti- sion patterns. Overall, these findings demonstrate tutive expression of TRAF1 and TRAF2 in Hodgkin the expression of several TRAF proteins in HD. Sig- and Reed–Sternberg (HRS) cells from archived nificantly, the altered regulation of selective TRAF paraffin-embedded tissues obtained from 21 pa- proteins may reflect HRS cell response to stimula- tients diagnosed with classical Hodgkin’s disease tion from the microenvironment and potentially (HD). In a selective portion of cases, examination of contribute both to apoptosis resistance and cell HRS cells for Epstein-Barr virus (EBV)–encoded maintenance of HRS cells.
    [Show full text]
  • Crystallographic Analysis of CD40 Recognition and Signaling by Human TRAF2
    Proc. Natl. Acad. Sci. USA Vol. 96, pp. 8408–8413, July 1999 Biochemistry Crystallographic analysis of CD40 recognition and signaling by human TRAF2 SARAH M. MCWHIRTER*, STEVEN S. PULLEN†,JAMES M. HOLTON*, JAMES J. CRUTE†,MARILYN R. KEHRY†, AND TOM ALBER*‡ *Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3206, and †Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877-0368 Communicated by Peter S. Kim, Massachusetts Institute of Technology, Cambridge, MA, May 26, 1999 (received for review April 25, 1999) ABSTRACT Tumor necrosis factor receptor superfamily proteins (8, 9). The biological selectivity of signaling also relies members convey signals that promote diverse cellular re- on the oligomerization specificity and receptor affinity of the sponses. Receptor trimerization by extracellular ligands ini- TRAFs. tiates signaling by recruiting members of the tumor necrosis The TNF receptor superfamily member, CD40, mediates factor receptor-associated factor (TRAF) family of adapter diverse responses. In antigen-presenting cells that constitu- proteins to the receptor cytoplasmic domains. We report the tively express CD40, it plays a critical role in T cell-dependent 2.4-Å crystal structure of a 22-kDa, receptor-binding fragment immune responses (10). TRAF1, TRAF2, TRAF3, and of TRAF2 complexed with a functionally defined peptide from TRAF6 binding sites in the 62-aa, CD40 cytoplasmic domain the cytoplasmic domain of the CD40 receptor. TRAF2 forms have been mapped (7, 11). TRAF1, TRAF2, and TRAF3 bind a mushroom-shaped trimer consisting of a coiled coil and a to the same sequence, 250PVQET, and TRAF6 binds to the unique ␤-sandwich domain. Both domains mediate trimer- membrane-proximal sequence, 231QEPQEINF.
    [Show full text]
  • TRAF6, a Molecular Bridge Spanning Adaptive Immunity, Innate Immunity and Osteoimmunology Hao Wu1* and Joseph R
    Review articles TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology Hao Wu1* and Joseph R. Arron2 Summary receptor/Toll-like receptor (IL-1R/TLR) superfamily. Gene Tumor necrosis factor (TNF) receptor associated factor targeting experiments have identified several indispen- 6 (TRAF6) is a crucial signaling molecule regulating a sable physiological functions of TRAF6, and structural diverse array of physiological processes, including and biochemical studies have revealed the potential adaptive immunity, innate immunity, bone metabolism mechanisms of its action. By virtue of its many signaling and the development of several tissues including lymph roles, TRAF6 represents an important target in the regu- nodes, mammary glands, skin and the central nervous lation of many disease processes, including immunity, system. It is a member of a group of six closely related inflammation and osteoporosis. BioEssays 25:1096– TRAF proteins, which serve as adapter molecules, coupl- 1105, 2003. ß 2003 Wiley Periodicals, Inc. ing the TNF receptor (TNFR) superfamily to intracellular signaling events. Among the TRAF proteins, TRAF6 is unique in that, in addition to mediating TNFR family Introduction signaling, it is also essential for signaling downstream of The tumor necrosis factor (TNF) receptor associated factors an unrelated family of receptors, the interleukin-1 (IL-1) (TRAFs) were first identified as two intracellular proteins, TRAF1 and TRAF2, associated with TNF-R2,(1) a member of 1Department of Biochemistry, Weill Medical College of Cornell the TNF receptor (TNFR) superfamily. There are currently six University, New York. mammalian TRAFs (TRAF1-6), which have emerged as 2Tri-Institutional MD-PhD Program, Weill Medical College of Cornell important proximal signal transducers for the TNFR super- University, New York.
    [Show full text]
  • Family in Amphioxus, the Basal Chordate TNF Receptor-Associated
    Genomic and Functional Uniqueness of the TNF Receptor-Associated Factor Gene Family in Amphioxus, the Basal Chordate This information is current as Shaochun Yuan, Tong Liu, Shengfeng Huang, Tao Wu, Ling of September 26, 2021. Huang, Huiling Liu, Xin Tao, Manyi Yang, Kui Wu, Yanhong Yu, Meiling Dong and Anlong Xu J Immunol 2009; 183:4560-4568; Prepublished online 14 September 2009; doi: 10.4049/jimmunol.0901537 Downloaded from http://www.jimmunol.org/content/183/7/4560 Supplementary http://www.jimmunol.org/content/suppl/2009/09/14/jimmunol.090153 Material 7.DC1 http://www.jimmunol.org/ References This article cites 38 articles, 12 of which you can access for free at: http://www.jimmunol.org/content/183/7/4560.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 26, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Genomic and Functional Uniqueness of the TNF Receptor-Associated Factor Gene Family in Amphioxus, the Basal Chordate1 Shaochun Yuan, Tong Liu, Shengfeng Huang, Tao Wu, Ling Huang, Huiling Liu, Xin Tao, Manyi Yang, Kui Wu, Yanhong Yu, Meiling Dong, and Anlong Xu2 The TNF-associated factor (TRAF) family, the crucial adaptor group in innate immune signaling, increased to 24 in amphioxus, the oldest lineage of the Chordata.
    [Show full text]
  • The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis
    cancers Review The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis 1, 2, , 1, Stephen P. Ducray y , Karthikraj Natarajan y z, Gavin D. Garland z, 1, , 2,3, , Suzanne D. Turner * y and Gerda Egger * y 1 Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB20QQ, UK 2 Department of Pathology, Medical University Vienna, 1090 Vienna, Austria 3 Ludwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria * Correspondence: [email protected] (S.D.T.); [email protected] (G.E.) European Research Initiative for ALK-related malignancies; www.erialcl.net. y These authors contributed equally to this work. z Received: 7 June 2019; Accepted: 23 July 2019; Published: 30 July 2019 Abstract: Anaplastic lymphoma kinase (ALK) is a tyrosine kinase involved in neuronal and gut development. Initially discovered in T cell lymphoma, ALK is frequently affected in diverse cancers by oncogenic translocations. These translocations involve different fusion partners that facilitate multimerisation and autophosphorylation of ALK, resulting in a constitutively active tyrosine kinase with oncogenic potential. ALK fusion proteins are involved in diverse cellular signalling pathways, such as Ras/extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase (PI3K)/Akt and Janus protein tyrosine kinase (JAK)/STAT. Furthermore, ALK is implicated in epigenetic regulation, including DNA methylation and miRNA expression, and an interaction with nuclear proteins has been described. Through these mechanisms, ALK fusion proteins enable a transcriptional programme that drives the pathogenesis of a range of ALK-related malignancies. Keywords: ALK; ALCL; NPM-ALK; EML4-ALK; NSCLC; ALK-translocation proteins; epigenetics 1. Introduction Anaplastic lymphoma kinase (ALK) was first successfully cloned in 1994 when it was reported in the context of a fusion protein in cases of anaplastic large cell lymphoma (ALCL) [1].
    [Show full text]
  • TRAF2 Sirna Set I TRAF2 Sirna Set I
    Catalog # Aliquot Size T57-911-05 3 x 5 nmol T57-911-20 3 x 20 nmol T57-911-50 3 x 50 nmol TRAF2 siRNA Set I siRNA duplexes targeted against three exon regions Catalog # T57-911 Lot # Z2097-85 Specificity Formulation TRAF2 siRNAs are designed to specifically knock-down The siRNAs are supplied as a lyophilized powder and human TRAF2 expression. shipped at room temperature. Product Description Reconstitution Protocol TRAF2 siRNA is a pool of three individual synthetic siRNA Briefly centrifuge the tubes (maximum RCF 4,000g) to duplexes designed to knock-down human TRAF2 mRNA collect lyophilized siRNA at the bottom of the tube. expression. Each siRNA is 19-25 bases in length. The gene Resuspend the siRNA in 50 µl of DEPC-treated water accession number is NM_021138. (supplied by researcher), which results in a 1x stock solution (10 µM). Gently pipet the solution 3-5 times to mix Gene Aliases and avoid the introduction of bubbles. Optional: aliquot TRAP, TRAP3, MGC: 45012 1x stock solutions for storage. Storage and Stability Related Products The lyophilized powder is stable for at least 4 weeks at room temperature. It is recommended that the Product Name Catalog Number lyophilized and resuspended siRNAs are stored at or TRAF2 Protein T57-30H below -20oC. After resuspension, siRNA stock solutions ≥2 Anti-TRAF2 T57-363BR µM can undergo up to 50 freeze-thaw cycles without Anti-TRAF2 T57-363R significant degradation. For long-term storage, it is Anti-TRAF3 T58-363R recommended that the siRNA is stored at -70oC. For most Anti-TRAF3 T58-363BR favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
    [Show full text]
  • Erythropoietin Action in Stress Response, Tissue Maintenance and Metabolism
    Int. J. Mol. Sci. 2014, 15, 10296-10333; doi:10.3390/ijms150610296 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Erythropoietin Action in Stress Response, Tissue Maintenance and Metabolism Yuanyuan Zhang 1, Li Wang 2, Soumyadeep Dey 1, Mawadda Alnaeeli 3,4, Sukanya Suresh 1, Heather Rogers 1, Ruifeng Teng 5 and Constance Tom Noguchi 1,* 1 Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA; E-Mails: [email protected] (Y.Z.); [email protected] (S.D.); [email protected] (S.S.); [email protected] (H.R.) 2 Faculty of Health Sciences, University of Macau, Macau SAR, China; E-Mail: [email protected] 3 Department of Biological Sciences, Ohio University, Zanesville, OH 43701, USA; E-Mail: [email protected] 4 Diabetes Institute, Ohio University, Athens, OH 45701, USA 5 Mouse Metabolism Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-301-496-1163; Fax: +1-301-402-0101. Received: 20 February 2014; in revised form: 23 May 2014 / Accepted: 28 May 2014 / Published: 10 June 2014 Abstract: Erythropoietin (EPO) regulation of red blood cell production and its induction at reduced oxygen tension provides for the important erythropoietic response to ischemic stress. The cloning and production of recombinant human EPO has led to its clinical use in patients with anemia for two and half decades and has facilitated studies of EPO action.
    [Show full text]
  • THE ROLE of TRAF6 PHOSPHORYLATION in Src/ TRAF6-MEDIATED IKK, JNK, Akt ACTIVATION and TUMORIGENESIS
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2014 THE ROLE OF TRAF6 PHOSPHORYLATION IN Src/ TRAF6-MEDIATED IKK, JNK, Akt ACTIVATION AND TUMORIGENESIS Yun Seong Jeong Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Biological Phenomena, Cell Phenomena, and Immunity Commons, and the Biology Commons Recommended Citation Jeong, Yun Seong, "THE ROLE OF TRAF6 PHOSPHORYLATION IN Src/TRAF6-MEDIATED IKK, JNK, Akt ACTIVATION AND TUMORIGENESIS" (2014). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 494. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/494 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. THE ROLE OF TRAF6 PHOSPHORYLATION IN Src/TRAF6-MEDIATED IKK, JNK, Akt ACTIVATION AND TUMORIGENESIS by Yun Seong
    [Show full text]
  • Lncrnas in the Type I Interferon Antiviral Response
    International Journal of Molecular Sciences Review LncRNAs in the Type I Interferon Antiviral Response 1 1 1, , 1,2,3, , Beatriz Suarez , Laura Prats-Mari , Juan P. Unfried * y and Puri Fortes * y 1 Program of Gene Therapy and Hepatology, Center for Applied Medical Research (CIMA), University of Navarra (UNAV), 31008 Pamplona, Spain; [email protected] (B.S.); [email protected] (L.P.-M.) 2 Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain 3 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28029 Madrid, Spain * Correspondence: [email protected] (J.P.U.); [email protected] (P.F.); Tel.: +34-948-194700 (ext. 814036) (J.P.U.); +34-948-194700 (ext. 814025) (P.F.) These authors contributed equally to this work. y Received: 14 August 2020; Accepted: 31 August 2020; Published: 3 September 2020 Abstract: The proper functioning of the immune system requires a robust control over a delicate equilibrium between an ineffective response and immune overactivation. Poor responses to viral insults may lead to chronic or overwhelming infection, whereas unrestrained activation can cause autoimmune diseases and cancer. Control over the magnitude and duration of the antiviral immune response is exerted by a finely tuned positive or negative regulation at the DNA, RNA, and protein level of members of the type I interferon (IFN) signaling pathways and on the expression and activity of antiviral and proinflammatory factors. As summarized in this review, committed research during the last decade has shown that several of these processes are exquisitely regulated by long non-coding RNAs (lncRNAs), transcripts with poor coding capacity, but highly versatile functions.
    [Show full text]
  • VIROCRINE TRANSFORMATION: the Intersection Between Viral Transforming Proteins and Cellular Signal Transduction Pathways
    P1: ARK/dat P2: ARS/vks QC: ARS July 18, 1998 14:57 Annual Reviews AR063-12 Annu. Rev. Microbiol. 1998. 52:397–421 Copyright c 1998 by Annual Reviews. All rights reserved VIROCRINE TRANSFORMATION: The Intersection Between Viral Transforming Proteins and Cellular Signal Transduction Pathways Daniel DiMaio,Char-Chang Lai, and Ophir Klein Department of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06510; email: [email protected] KEY WORDS: viral oncogenes, bovine papillomavirus E5 protein, spleen focus-forming virus gp55, polyomavirus middle T antigen, Epstein-Barr virus LMP-1 ABSTRACT This review describes a mechanism of viral transformation involving activation of cellular signaling pathways. We focus on four viral oncoproteins: the E5 protein of bovine papillomavirus, which activates the platelet-derived growth factor receptor; gp55 of spleen focus forming virus, which activates the erythropoietin receptor; polyoma virus middle T antigen, which resembles an activated receptor tyrosine kinase; and LMP-1 of Epstein-Barr virus, which mimics an activated tu- mor necrosis factor receptor. These examples indicate that diverse viruses induce cell transformation by activating cellular signal transduction pathways. Study of this mechanism of viral transformation will provide new insights into viral tumorigenesis and cellular signal transduction. by University of California - San Francisco on 12/29/06. For personal use only. Annu. Rev. Microbiol. 1998.52:397-421. Downloaded from arjournals.annualreviews.org
    [Show full text]
  • A Critical Role for TNF Receptor-Associated Factor 1 and Bim Down-Regulation in CD8 Memory T Cell Survival
    A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival Laurent Sabbagh*, Cathy C. Srokowski*, Gayle Pulle*, Laura M. Snell*, Bradley J. Sedgmen*, Yuanqing Liu*, Erdyni N. Tsitsikov†, and Tania H. Watts*‡ *Department of Immunology, University of Toronto, 1 King’s College Circle, Toronto, ON, Canada M5S 1A8; and †CBR Institute for Biomedical Research, Harvard Medical School, WAB 124, 200 Longwood Avenue, Boston, MA 02468 Edited by Philippa Marrack, National Jewish Medical and Research Center, Denver, CO, and approved October 16, 2006 (received for review April 10, 2006) The mechanisms that allow the maintenance of immunological involved in the promotion as well as feedback inhibition of TRAF2- memory remain incompletely defined. Here we report that tumor mediated signaling events. necrosis factor receptor (TNFR)-associated factor (TRAF) 1, a protein In T cells, TRAF1 deficiency results in hyperresponsiveness to recruited in response to several costimulatory TNFR family mem- anti-CD3 and TNF stimulation in vitro, suggesting that TRAF1 is bers, is required for maximal CD8 T cell responses to influenza virus a negative regulator of T cell activation (14). In contrast, constitu- in mice. Decreased recovery of CD8 T cells in vivo occurred under tive overexpression of a TRAF1 transgene in a T cell antigen conditions where cell division was unimpaired. In vitro, TRAF1- receptor (TCR) transgenic model led to reduced antigen-induced deficient, antigen-activated T cells accumulated higher levels of the cell death (15). However, the effect of TRAF1 deficiency on proapoptotic BH3-only family member Bim, particularly the most antigen-specific T cell responses in vivo has not yet been analyzed.
    [Show full text]